Hemispherx Biopharma Inc (HEB)

HEB on American Stock Exchange

0.21USD
21 May 2013
Price Change (% chg)

$0.00 (+0.87%)
Prev Close
$0.21
Open
$0.20
Day's High
$0.21
Day's Low
$0.20
Volume
683,182
Avg. Vol
541,592
52-wk High
$1.10
52-wk Low
$0.18

HEB

Chart for HEB

About

Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Hemispherx focuses on two core pharmaceutical technology platforms Ampligen... (more)
No analyst recommendations are available for HEB.

Overall

Beta: 1.24
Market Cap (Mil.): $34.47
Shares Outstanding (Mil.): 167.23
Dividend: --
Yield (%): --

Financials

  HEB Industry Sector
P/E (TTM): -- 54.65 35.85
EPS (TTM): -0.12 -- --
ROI: -41.57 0.83 18.76
ROE: -41.99 1.79 19.57
Search Stocks

Hemispherx says FDA rejects fatigue drug application

- Hemispherx Biopharma Inc said U.S. regulators had declined to approve its new drug application for Ampligen, its experimental drug for treating chronic fatigue syndrome, five years after the company first filed for the drug's approval.

04 Feb 2013

Hemispherx says FDA rejects fatigue drug application

Feb 4 - Hemispherx Biopharma Inc said U.S. regulators had declined to approve its new drug application for Ampligen, its experimental drug for treating chronic fatigue syndrome, five years after the company first filed for the drug's approval.

04 Feb 2013

Competitors

  Price Change
Pfizer Inc. (PFE.N) $28.75 +0.05
Novartis AG (NOVN.VX) CHF72.40 +0.65
Merck & Co., Inc. (MRK.N) $46.87 +1.66
AstraZeneca plc (AZN.L) 3,394.50p +4.00
GlaxoSmithKline plc (GSK.L) 1,742.00p +20.50
Baxter International Inc. (BAX.N) $73.02 +0.08
Genta Incorporated (GNTAQ.PK) $0.00 +0.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: GlobalData
$250.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: TheStreet.com Ratings
$10.00
Provider: ValuEngine, Inc.
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks